AsiDNA (a DNA Repair Inhibitor) Administered IntraVenously in Advanced Solid Tumors
Clinical trial NCT03579628 · COMPLETED
Trial details
- NCT number
- NCT03579628
- Sponsor
- Valerio Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-05
- Primary completion
- 2021-02-24
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.